Outcome of acute myocardial infarction according to the specialty of the admitting physician

The New England Journal of Medicine
J G JollisD B Mark

Abstract

In order to limit costs, health care organizations in the United States are shifting medical care from specialists to primary care physicians. Although primary care physicians provide less resource-intensive care, there is little information concerning the effects of this strategy on outcomes. We examined mortality according to the specialty of the admitting physician among 8241 Medicare patients who were hospitalized for acute myocardial infarction in four states during a seven-month period in 1992. Proportional-hazards regression models were used to examine survival up to one year after the myocardial infarction. To determine the generalizability of our findings, we also examined insurance claims and survival data for all 220,535 patients for whom there were Medicare claims for hospital care for acute myocardial infarction in 1992. After adjustment for characteristics of the patients and hospitals, patients who were admitted to the hospital by a cardiologist were 12 percent less likely to die within one year than those admitted by a primary care physician (P<0.001). Cardiologists also had the highest rate of use of cardiac procedures and medications, including medications (such as thrombolytic agents and beta-blockers) that a...Continue Reading

References

Apr 4, 1992·JAMA : the Journal of the American Medical Association·S GreenfieldJ E Ware
Oct 14, 1988·JAMA : the Journal of the American Medical Association·S YusufL Friedman
Sep 1, 1995·Journal of the American College of Cardiology·T L SchreiberW W O'Neill

❮ Previous
Next ❯

Citations

Mar 17, 2005·JAMA : the Journal of the American Medical Association·Saif S RathoreHarlan M Krumholz
Jun 1, 1997·Arthritis Care and Research : the Official Journal of the Arthritis Health Professions Association·J N KatzD W Bates
Sep 27, 2000·Diseases of the Colon and Rectum·L E Smith
Apr 12, 2003·The American Journal of Medicine·Karen P Alexander, Eric D Peterson
Nov 4, 2000·The American Journal of Medicine·E Yelin
Dec 5, 1997·The Annals of Thoracic Surgery·R W Anderson
Nov 5, 1999·Obstetrics and Gynecology·D P ShackelfordD E Jones
Mar 17, 1999·International Journal of Cardiology·R F HellerP Tatsanavivat
Aug 31, 2001·Journal of the American College of Cardiology·R H MehtaH M Krumholz
Aug 31, 2001·Journal of the American College of Cardiology·G A Beller
Aug 31, 2001·Journal of the American College of Cardiology·D P Zipes
Jun 27, 2002·Journal of the American College of Cardiology·D A AlterJ V Tu
Feb 7, 2003·Journal of the American College of Cardiology·Maria AnsariBarry M Massie
Feb 7, 2003·Journal of the American College of Cardiology·Todd M Koelling, Kim A Eagle
Mar 1, 1997·Journal of the American College of Cardiology·I S NashV Fuster
Oct 13, 1998·Journal of the American College of Cardiology·P N CasaleL M Eby
Nov 11, 1998·Journal of the American College of Cardiology·R S Stafford, D Blumenthal
Apr 8, 1999·Journal of the American College of Cardiology·S G EllisE J Topol
Jun 11, 1999·Journal of the American College of Cardiology·N R EveryH V Barron
Feb 12, 2002·European Journal of Internal Medicine·John Kellett
Sep 13, 2002·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Paula A Johnson, Rachael S Fulp
Mar 21, 1998·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·M S Verani
Feb 24, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·R NussM Manco-Johnson
May 8, 2002·Emergency Medicine·Brendon Smith
Jan 5, 2000·Kidney International·B J Pereira
Oct 27, 2001·Journal of General Internal Medicine·D G FairchildD W Bates
Jan 20, 2004·Advances in Renal Replacement Therapy·Lesley Ann Stevens, Adeera Levin
Dec 19, 1996·The New England Journal of Medicine·L Goldman
May 29, 1997·The New England Journal of Medicine·B Starfield
Apr 2, 1998·The New England Journal of Medicine·J G Jollis, P S Romano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved